Bruker Daltonics To
Webcast Q3 Conference Call On November 4, 2002
BILLERICA, Mass., Oct
24, 2002 (BUSINESS WIRE) -- Bruker Daltonics Inc. (NASDAQ: BDAL)
plans to release its third quarter financial results on Monday, November
4, 2002 after the market closes. The company will then host a live
streaming-audio CCBN webcast of its operator-assisted earnings conference
call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) that same day. To
listen to the webcast, investors can go to www.bdal.com
, and then click on the live web broadcast symbol. The on-demand webcast
will be available through the company web site for 30 days.
Investors can also listen
and participate on the telephone in the US and Canada by calling
888-482-0024 or 617-801-9702 outside the US and Canada. Investors should
refer to the Bruker Daltonics Third Quarter Earnings Call. A telephone
replay of the conference call will be available for three days, beginning
thirty minutes after the completion of the conference. The replay will be
available by dialing toll-free 888-286-8010 in the US and Canada or
617-801-6888 outside the US and Canada, and then entering replay pass code
64682.
ABOUT BRUKER DALTONICS
Bruker Daltonics is a
leading provider of innovative life science tools based on mass
spectrometry. Its substantial investment in research and development
allows it to design, manufacture and market a broad array of products
intended to meet the rapidly growing needs of a diverse customer base,
including pharmaceutical companies, biotechnology companies, proteomics
companies, molecular diagnostics companies, academic institutions and
government agencies. Bruker Daltonics has diverse technology platforms
that integrate automated sample preparation and clean-up, advanced
front-end AnchorChip(TM) MALDI targets and API source technology with
cutting-edge proprietary MALDI-TOF, MALDI-TOF/TOF, ESI-TOF, ESI-Q-q-TOF,
ion trap and FTMS mass analyzers, as well as analysis and bioinformatics
software. Bruker Daltonics is also a worldwide leader in supplying mass
spectrometry-based systems for substance detection and pathogen
identification in security, defense and anti-terrorism applications.
Further information is available at: www.bdal.com
.
CAUTIONARY STATEMENT
Any statements contained in
this press release that do not describe historical facts may constitute
forward-looking statements as that term is defined in the Private
Securities Litigation Reform Act of 1995. Any forward-looking statements
contained herein are based on current expectations, but are subject to a
number of risks and uncertainties. The factors that could cause actual
future results to differ materially from current expectations include, but
are not limited to, risks and uncertainties relating to technological
approaches, product development, manufacturing, market acceptance, cost
and pricing of Bruker Daltonics' products, dependence on collaborative
partners, suppliers, FDA and other regulatory approvals to the extent
applicable, competition, the intellectual property of others, patent
protection and litigation and other risk factors discussed from time to
time in Bruker Daltonics' reports or filings with the Securities and
Exchange Commission. Bruker Daltonics expressly disclaims any obligation
to update the information contained herein.
CONTACT:
Bruker Daltonics, Billerica
Michael Willett, 978/663-3660 ext. 1411
Michael.Willett@bdal.com
www.bdal.com
